Mako Gold Ltd (ASX:MKG) Announces Merger with Aurum Resources
Mako Gold Ltd confirms a merger with Aurum Resources, offering shareholders a premium and strengthening its financial and operational position.
Mako Gold Limited (ASX:MKG) Reports Quarterly Cash Flow Update
Mako Gold Limited (ASX:MKG) reports on its quarterly cash flow, highlighting cash outflows and strategic funding amidst a takeover offer.
Magnum Mining and Exploration Limited (ASX:MGU) Quarterly Cash Flow Report
Magnum Mining (ASX:MGU) reports cash flow results, revealing operational expenditures and the cash position for the quarter ended December 31, 2024.
Avecho Biotechnology Limited (ASX: AVE) Reports Q4 Activities
Avecho Biotechnology Limited reports progress in its Phase III CBD clinical trial and significant manufacturing achievements in Q4 2024.
Magnum Mining & Exploration Ltd (ASX:MGU) Quarterly Activities Report
Magnum Mining announces its strategic acquisition of rare earth projects in Brazil and advances its Green Pig Iron Project negotiations in Saudi Arabia.
Zenith Minerals Limited (ASX:ZNC) Reports Strong Quarterly Performance
Zenith Minerals (ASX:ZNC) announces a productive quarter with significant resource increases and a strengthened financial position.
Eclipse Metals Ltd (ASX:EPM) Reports Strong Operational Progress
Eclipse Metals Ltd reports significant operational progress and resource development in its quarterly activities report.
Clara Resources Limited (ASX:C7A) Reports December Quarter Activities
Clara Resources Limited (ASX:C7A) reports on its December quarter activities, highlighting key developments in exploration, capital management, and financial performance.
DXN Limited (ASX:DXN) Reports Strong Q2 FY25 Results
DXN Limited reports a revenue increase of 58.1% in Q2 FY25 and successfully raises $6.5 million to enhance operations.
Paradigm Biopharmaceuticals Ltd. (ASX: PAR) Announces Key Achievements in Quarterly Report
Paradigm Biopharmaceuticals announces key achievements in its December 2024 quarterly activities, including successful FDA protocol clearance and financial highlights.